FluoGuide
49.25 SEK -4.55%HC Andersen Capital has previously received payment from FluoGuide for a Digital IR/Corporate Visibility agreement. This means that there may be paid material that is not updated. See disclaimer.
5 investors are following this company
FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
FLUO
Daily low / high price
47.5 / 55
SEK
Market cap
601.26M SEK
Turnover
515.27K SEK
Volume
10K
Latest videos
Financial calendar
Interim report
2024-05-30
Interim report
2024-08-29
Interim report
2024-11-28
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Life Science IVS | 17.7 % | 17.7 % |
Wexotec ApS | 12.4 % | 12.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Minutes from Annual General Meeting in FluoGuide A/S
HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools